ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTER01

Development of AI-Augmented quality assurance tools for radiation therapy

Active
Institution
Stanford University, CA
Principal investigator
Lei Xing
Funding
$515K
Duration
2023–2028
Open portfolio

Moonbase score

Still being scored

Abstract

Development of AI-Augmented quality assurance tools for radiation therapy Project summary Quality assurance (QA) is an essential part of radiation therapy (RT) workflow and critically determines the success of patient care. However, current treatment plan QA methods and tools are deficient in multiple aspects and suffer from problems such as limited accountability, labor intensive, and costly. In this project we will leverage the emerging deep learning techniques to create clinically translatable solutions for robust and efficient QA of modern RT. Specifically, we aim to (i) establish a novel framework for using deep learning to verify the machine delivery parameters of an RT treatment plan; (ii) investigate the use of deep learning for RT dose verification; and (iii) evaluate the performance of the QA system and show its potential clinical impact . This research presents the first-of-its-kind treatment plan QA strategy capable of providing both machine delivery parameters (MLC apertures and MUs of the involved IMRT/VMAT fields) and dosimetric distribution on the patient’s treatment geometry. The research will also make it possible to take advantage of the useful features of both deep learning models from Aims 1 and 2 and check the cycle-consistency of a treatment plan (i.e., from the beam parameters of the plan to the corresponding 3D dose distribution, and then from the 3D dose to the beam parameters) for enhanced plan QA. Successful completion of the project will provide urgently needed plan QA tools for safe, efficient and high-quality RT practice, and enable patients to truly benefit from modern RT modalities. Finally, the proposed strategy is quite broad and can be readily generalized for QA of other treatment modalities, such as proton therapy and high-dose rate (HDR) brachytherapy.

LOADING MOONBASE SCORE

R01NATIONAL CANCER INSTITUTESpecial Emphasis Panel[ZRG1-SBIB-S(57)R]parametersradiationdeep learningradiation therapyquality assurancedosebeamassurance

Questions for Stanford University

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.